Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

The Effect of Intermittent Rifampicin on Raltegravir (RIFRAL)

This study has been completed.
Royal Liverpool and Broadgreen University Hospitals NHS Trust
Information provided by (Responsible Party):
Helen Reynolds, University of Liverpool Identifier:
First received: August 24, 2011
Last updated: October 30, 2013
Last verified: October 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2013
  Primary Completion Date: June 2013 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):